Nucleot(s)ide analogues for hepatitis B virus-related hepatocellular carcinoma after curative treatment: a systematic review and meta-analysis.
<h4>Aim</h4>The benefit of nucleot(s)ide analogues (NA) for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) after curative treatment has been widely debated due to the relatively weak evidence. The objective of this systematic review was to evaluate the effect of NA on rec...
Saved in:
| Main Authors: | Ping Sun, Xiaochuan Dong, Xiang Cheng, Qinggang Hu, Qichang Zheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0102761 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of nucleos(t)ide analogues on the risk of hepatocellular carcinoma in chronic hepatitis B patients: a time-dependent Cox regression analysis
by: Makoto Moriyama, et al.
Published: (2025-06-01) -
Impact of nucleos(t)ide analogue therapy on the incidence of Alzheimer’s disease in patients with chronic hepatitis B virus infection
by: Jihye Lim, et al.
Published: (2025-04-01) -
Association of nucleos(t)ide analogue therapy with Parkinson disease in chronic hepatitis B patients
by: Jihye Lim, et al.
Published: (2025-04-01) -
Association of Hepatitis B Virus Polymerase/Surface Gene Overlap Mutations Developed in Nucleos(t)id Analogue Treatments of Chronic Hepatitis B with Hepatocellular Carcinoma
by: Yeşim Saliha Gürbüz, et al.
Published: (2025-04-01) -
Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos(t)ide analogue therapy
by: Tingyan Wang, et al.
Published: (2025-01-01)